According to Medpace's latest financial reports the company has a price-to-book ratio of 21.9.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 16.8 | -1.58% |
2022-12-31 | 17.1 | 108.29% |
2021-12-31 | 8.21 | 32.83% |
2020-12-31 | 6.18 | 48.04% |
2019-12-31 | 4.17 | 30.39% |
2018-12-31 | 3.20 | 25.47% |
2017-12-31 | 2.55 | 6.08% |
2016-12-31 | 2.41 | |
2015-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.43 | -88.91% | ๐บ๐ธ USA |